Clinical Trial Update: A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study of a new medicine NNC0363-1063 in participants with Type 1 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0363-1063

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: RECRUITING